Stockreport

Iterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA

Iterum Therapeutics plc - Ordinary Share  (ITRM) 
Last iterum therapeutics plc - ordinary share earnings: 11/12 04:30 pm Check Earnings Report
PDF --SPA supports protocol for Phase 3 Clinical Trial of Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections-- --Clinical Trial Expected to Begin En [Read more]